Promentis Pharmaceuticals, Inc. recently announced it will enter an exclusive agreement with UM to commercialize a discovery made by a team of UM faculty scientists that has the potential to treat brain cancer and possibly other disorders of the central nervous system.
from The Medical News http://ift.tt/1DZEiP3
from The Medical News http://ift.tt/1DZEiP3
No comments:
Post a Comment